HomeLatestHigh Food Prices Won’t Bring Me Down this Thanksgiving
High Food Prices Won’t Bring Me Down this Thanksgiving
November 23, 2021 at 8:46 am - by Kevin Flynn
The struggle is real. My wife and I did our annual Thanksgiving shopping this weekend and easily spent 50% more than we did last year. No, we didn’t increase the size of the guest list or decide to try some fancy new recipe. The price tag was $450, and we bought less than we normally do. Last year’s bill was just north of $300. Do you share my pain?
I’ve written about it for months and knew that food prices were up from last year. That didn’t prevent the sticker shock from a $35 pre-sliced spiral ham. I’ll cut it myself, thank you. The unsliced version cost me $12. I could hear my mom applauding when I bought it. She grew up during the Great Depression. Bargain shopping was a way of life for her generation.
Why Rising Prices are a Reason to Be Grateful
An individual much wiser than myself once told me, “If that’s the worst thing to happen to you today, you’re having a pretty good day.” Sure, food prices are up, but so are the returns on my portfolio. Rising prices are not necessarily a bad thing for investors. Just ask the shareholders at Empire Petroleum (EMPR). Their stock is up 800% this year.
My gratitude speaks when I care and when I share, so today I’m going to share some insights on food investments. Let’s start with PBJ. No, we’re not talking about the iconic sandwich. The Invesco Dynamic Food & Beverage ETF (PBJ) is up a solid 20.75% this year. I bought them back in 2005 at $14.71. They opened at $43.12 this morning.
Food investments are risky, so most traditional investors avoid them. I often buy stocks on a whim, not blindly, but randomly. One of those is the iPath Series B Bloomberg Coffee Subindex Total Return ETN (JO). I scoped it out one morning while having my first cup of coffee. They’re up 70.04% this year. Think about that when you have your next cup of Joe.
I’d love to tell you to invest in beef, but the iPath Series B Bloomberg Livestock Subindex Total Return ETN (COW) is only up 9.44%% this year. That doesn’t cover rising food prices. Try corn instead. The Teucrium Corn Fund (CORN) is showing a 38% gain in 2021. Tell that to your friends who say those cobs have no real nutritional value.
Gratitude is an Action Word
Our team here at Investor’s Prism would like to thank all of you for engaging with our platform this year. As an expression of our gratitude, we’ll be adding additional writers and some new features in the coming months. That will begin next week, so be sure to visit us often. We want to share our investor insights with you as we move closer to what looks like a profitable 2022.
Gratitude is an action word. Our goal has always been to push for the democratization of financial markets and help more people build wealth through investing and trading. If you have benefitted from that, please share a piece of what you’re earned with those less fortunate than you this holiday. As Winston Churchill once said, “We make a living by what we get, but we make a life by what we give.” Have a happy and safe holiday.
Share this article:
Disclaimer
This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…
This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.
“PCG” and its affiliates are not a registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does “PCG” engage in any activities that would require such registrations. “PCG” and its affiliates do not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced in this communication.
Our articles, reports/releases and videos are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We only publish favorable information because we are compensated to publish only favorable information. We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest.
The contributors may buy and sell securities before, during and after any particular article, report and publication. In no event shall “PCG” or affiliates be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by “PCG”, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages.Further, nothing in this communication is intended to provide tax, legal, or investment advice and nothing in this communication should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. Never invest in any stock featured by “PCG” and its affiliates unless you can afford to lose your entire investment.We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and investment advisers. An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. We encourage our readers to invest carefully and read the investor information available at the web sites of the U.S. Securities and Exchange Commission (SEC) at www.sec.gov and the Financial Industry Regulatory Authority (FINRA) at www.finra.org.
For full disclaimers, including compensation received for professional services, please visit www.pcgadvisory.com/disclosures.
“Rare” or “orphan” diseases aren’t so rare anymore. Today, there are about 300 million people worldwide, including one in 10…
Share This Article
About the Author
Kevin Flynn
A former financial professional and founder of AdvisorScale Financial Writing, Kevin lives in Leominster, Massachusetts with his wife Evelyn, two cats, and nine wonderful grandchildren.
